{"id":"W4406486248","doi":"10.1136/bmjophth-2024-001967","title":"Switching to faricimab from the current anti-VEGF therapy: evidence-based expert recommendations","year":2025,"lang":"en","type":"review","venue":"BMJ Open Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; University of Ottawa; University of Toronto","funders":"Novo Nordisk; Apellis Pharmaceuticals; Regeneron Pharmaceuticals; Alimera Sciences; Bausch Health; Astellas Pharma; F. Hoffmann-La Roche; Biogen","keywords":"Macular degeneration; Medicine; Ophthalmology; Ranibizumab; Visual acuity; Retina; Retinal; Vascular endothelial growth factor; Vitrectomy; VEGF receptors; Bevacizumab; Surgery; Internal medicine; Neuroscience; Chemotherapy; Psychology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005969548,0.00135303,0.003811384,0.003439052,0.0004485154,0.002110303,0.00380478,0.003614595,0.009136306],"category_scores_gemma":[0.01293035,0.0005949051,0.004682791,0.002617256,0.0006483467,0.00202627,0.0009465714,0.003163277,0.002378537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002284433,"about_ca_system_score_gemma":0.005485574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004690968,"about_ca_topic_score_gemma":0.008398272,"domain_scores_codex":[0.9967077,0.0009518253,0.001060723,0.0002366626,0.0009042663,0.000138761],"domain_scores_gemma":[0.9924418,0.003929402,0.001403697,0.0001212477,0.001900091,0.0002036812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003194427,0.00007336518,0.0002442822,0.2131508,0.001889104,0.0002370835,0.0001385457,0.0003567602,0.0005432074,0.002665093,0.1234036,0.6569787],"study_design_scores_gemma":[0.000433291,0.0001067849,0.001124335,0.3194624,0.005464831,0.0004668702,0.0001259811,0.0001842911,0.0002823,0.003746013,0.6685469,0.00005589625],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001607224,0.9863094,0.0004529543,0.008513625,0.001616927,0.0002286365,0.0003207354,0.00003138108,0.002365535],"genre_scores_gemma":[0.001742626,0.9872243,0.002373568,0.006255807,0.0004977435,0.0002197865,0.0004169116,0.00001031218,0.00125895],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009136306,"threshold_uncertainty_score":0.03157037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.373294687787905,"score_gpt":0.5592249945097021,"score_spread":0.1859303067217971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}